Clinical Trials Directory

Trials / Completed

CompletedNCT00510458

LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study

LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study - An Open Label, Prospective, Post-market, Multi-center Clinical Evaluation of the LFIT™ Anatomic CoCr Femoral Heads With X3® Inserts

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
89 (actual)
Sponsor
Stryker Orthopaedics · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Total hip replacement surgery is considered to be a very successful surgical procedure for the treatment of degenerative joint disease. The purpose of the study is to evaluate a large size (36mm, 40mm or 44mm) femoral (hip) head called the LFIT™ Anatomic CoCr Femoral Head (Low Friction Ion Treatment). The large size femoral heads will be used with the Trident® X3® polyethylene (plastic) inserts and will be compared with a historical control. Study Hypothesis: The linear wear rate for hips implanted with the LFIT™ Anatomic CoCr Femoral Head is no worse than 0.08 mm wear per year at 5 years post-surgery.

Conditions

Interventions

TypeNameDescription
DEVICELFIT™ Femoral Heads With X3® InsertLFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement

Timeline

Start date
2007-04-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2007-08-02
Last updated
2018-03-12
Results posted
2018-03-12

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00510458. Inclusion in this directory is not an endorsement.